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Abstract
In a world with a constantly growing and aging
population, health is a precious asset. Presently, with
machine learning (ML), a technological change is
taking place that could provide high quality healthcare
and especially, improve efficiency of medical
diagnostics in clinics. However, ML needs to be deeply
integrated in clinical routines which highly differs from
the integration of previous health IT given the specific
characteristics of ML. Since existing literature on the
adoption of ML in medical diagnostics is scarce, we set
up an explorative qualitative study based on a
conceptual basis consisting of the technologicalorganizational-environmental framework (TOE) and
the healthcare specific framework of non-adoption,
abandonment, scale-up, spread, and sustainability
(NASSS). By interviewing experts from clinics and
their suppliers we were able to connect both
frameworks and identify influencing factors specific to
the adoption process of ML in medical diagnostics.

1. Introduction
The ongoing digitalization influences the society
and business world, including the healthcare sector as a
whole. For instance, the integration of health
information technologies (HIT) in clinics such as
electronic health records enables significant
improvements in therapy, rehabilitation, or diagnostics
[21]. However, this new technological opportunities
also lead to challenges within clinics: Physicians have
to deal with an ever-increasing amount of patient’s
data created by digitized systems [4]. In addition,
clinics currently face major societal issues: The high
number of aging-related diseases caused by
demographic change is—for example—further
increased by the global COVID-19 pandemic crisis, so
that the resources of medical personnel become
progressively strained [27]. Artificial intelligence (AI)
as the “science and engineering of making intelligent
machines, especially intelligent computer programs”
[31:2] could help solving such challenges and makes it
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possible to technically solve tasks that were previously
reserved for human intelligence [38]. Especially,
machine learning (ML) as a subfield of AI is currently
one of the most rapidly growing technological
opportunities. Thus, in this research paper, we focus on
ML, which enables information systems (IS) to
improve themselves automatically through training
experience [8, 23]. ML systems have the enormous
potential to process complex patient data (e.g. medical
images or text data) effectively, find hidden patterns in
symptoms, and link them to possible diseases. In this
regard, the use of ML systems for diagnostics could
enable more profound and efficient diagnoses and
could thus be decisive for life or death [18, 42].
However, ML systems also pose challenges, which
prevents a wide-spread implementation in clinics so far
[24]. This is particularly the case as ML systems differ
from other HIT as they are able to adapt their behavior
over time, operate as black boxes, derive results
statistically, and can thus lead to erroneous decisions
[8].
IS research has recently begun to investigate the
chances and challenges of ML in healthcare. For
example, it has been analyzed what ML systems can
contribute to improve medical processes and, in
particular, medical diagnostics [e.g. 19, 25].
Furthermore, technical research is being done to
demonstrate the feasibility of ML systems’ application
in medicine [e.g. 3, 29]. However, prior studies have
not yet contributed sufficiently to an understanding of
clinics’ adoption process of ML systems. In that
regard, our research aims to identify: Which specific
factors influence the readiness of clinics to adopt ML
systems and subsequently implement such systems for
medical diagnostics? To answer this question, we
conducted a qualitative study based on interviews with
experts working for clinics or their suppliers. In order
to sort our key findings, we refer to the technologicalorganizational-environmental (TOE) framework and
the framework of non-adoption, abandonment, scaleup, spread and sustainability (NASSS) as a conceptual
basis [12, 17].
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2. Theoretical background
ML systems are based on algorithms capable of
extrapolating patterns from data [39]. The acquired
patterns can then be applied to new data in order to
make, for example, classifications. As a consequence,
ML systems are able to solve tasks without receiving
explicit instructions but by learning from training
examples. These examples can either be labelled (e.g.
symptoms and related condition) or without any
annotation (e.g. symptoms), resulting in a respective
supervised or unsupervised ML problem [8]. Due to
the data-based learning approach, an inherent property
of ML systems is that they can be adapted to new data
and evolve over time if being retrained [39].
Reaching from prediction of patient traffic in
clinics to support of therapies: ML systems can help
solving various problems in medicine [42, 43].
However, one of the most prominent areas of
application in research and practice are medical
diagnostics [e.g. 35, 41]. In this context, ML systems
(and especially deep neural networks) can help to
identify patterns in medical data (e.g. in medical scans,
pathology slides, electrocardiograms) and sort possible
conditions according to their likelihood [18, 44]. A
distinction can be made whether ML serves to take
over entire areas of responsibility from doctors or to
support them in their decision-making process. In the
near future, ML systems will mainly be used as an
intelligent decision support rather than to automate
medical diagnostics fully [e.g. 18, 25]. In this sense,
current practical examples such as Isabel Health (an
ML based symptom checker) show that more and more
of such assistive ML systems are presently finding
their way into clinics [46]. These systems raise the
hope of making medical diagnostics faster, more
efficient, and consistent and thus more valuable since
they are able to compare patients’ data with a database
that is larger than any physician’s experience [18, 42].
However, the introduction of ML systems in clinics
also poses major challenges as these systems highly
differ from conventional HIT. ML systems learn from
high volumes of data, instead of being explicitly
programmed [39]. It is therefore imperative to share
data across clinics to enable profound training of the
ML system [18]. Provided that ML systems are based
on appropriate data, they are able to prepare high
stakes diagnostic decisions (e.g. by suggesting possible
conditions) [25]. ML systems derive these solutions
based on statistical methods, which leads to several
consequences: Modern ML systems are not only
becoming increasingly opaque, they also never lead to
100% accuracy [8, 25]. These properties are
particularly problematic in a medical setting where
patients’ lives depend on a profound diagnosis and the

correct functionality of the ML system should be
ensured at any time [25]. Given the specific
characteristics of ML systems, a wide-spread adoption
in clinics has not been achieved so far, requiring more
detailed investigation by research [24].
In order to gain an overview of existing literature
regarding the adoption process of ML systems in
clinics, a systematic literature review was conducted
and published by the authors [37]. Looking at the
articles identified, it becomes clear that most of the
publications do not include primary empirical studies
to identify factors influencing the adoption process of
ML systems in clinics. Furthermore, none of the
publications based their research on pertinent theories
in order to develop a holistic understanding of the
adoption process in clinics. Even though, ML systems
are highly relevant in medicine, there is thus a lack of
empirical and theoretically profound research. Against
this background, an investigation of the challenges
related to the adoption process of ML systems in
clinics is desirable. To gain deeper insights into this
research field, it is important to differentiate that the
adoption process of innovations in organizations
consists of two main phases comprising: (1) The initial
readiness for a technology and (2) its subsequent
implementation within the organization [50]. Both
steps are highly relevant to the success of a technology
within an organization and should be considered as
dependent from each other [45]. The two-stage
adoption process is a complex, multi-dimensional
process that is difficult to represent using a single
theory. In line with the recommendations of Mayer and
Sparrowe (2013), we therefore base our research on
“two theories to address what neither theory could
[explain] independently” [30:917]. We thus utilize two
frameworks to investigate the factors that influence a
clinic’s process from (1) the first readiness to (2) the
implementation of ML systems. Accordingly, we chose
to employ both (1) the TOE framework developed by
DePietro et al. (1990) [12] and (2) the NASSS
framework [17] as a conceptual basis.
The TOE framework is widely used in IS research
to understand the readiness of an organization to adopt
a new technological innovation [e.g. 1, 47]. In this
regard, it considers three domains: The technological,
organizational, and the environmental context. Each
context, in turn, comprises several factors that specify
on the considered domain. Those are for example the
characteristics of the investigated technology
(technological context), the existing infrastructure
within an organization (organizational context), or
governmental regulations concerning a technology
(environmental context) [12]. In the last few years,
clinics are increasingly faced with technological
change and have to decide which technologies are
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relevant to them [2]. In that regard, several studies
have used and adapted the TOE framework to explain
the factors that influence the readiness of a clinic to
adopt an HIT, although the framework was not
originally established for the healthcare industry [e.g.
22, 28]. Thus, we consider the theoretical framework to
be a useful starting point to investigate what enables
clinics to prepare for the adoption of ML systems.
Presently, adoption research in health informatics
started to look beyond the mere readiness and towards
the implementation phase after the adoption actually
took place [17]. In this context, ML systems own
highly specific characteristics that will necessitate a
significant change in the organization’s structure and
working routines in the long run [8, 25]. Therefore, the
implementation phase after the first readiness to adopt
is just as decisive for the success of ML systems in
clinics as the previous one. To capture this, we
included the NASSS technology implementation
framework as a second conceptual basis. NASSS has
primarily been developed for the healthcare context by
combining established health- and social care
frameworks and can be used to analyze the
implementation phase of an HIT. It includes seven
domains such as the condition to be diagnosed and
treated, the demand- and supply-side value proposition
associated with an HIT, and the adopter system
consisting of patients, their relatives and medical staff.
Furthermore, it explicitly conceptualizes on the
embedding and adaptation of the HIT within a clinic
over time [17]. In summary, the factors of NASSS help
to complement the TOE framework to account for the
whole adoption process of a HIT in clinical processes.
Since ML systems differ significantly from existing
technologies and it is not sufficient to rely on either the
basic TOE or NASSS framework [49], we seek to
combine, adapt, and extend both frameworks in the
following to gain a profound understanding about the
specific factors that enable clinics to put ML systems
into clinical practice.

3. Qualitative research methodology
Our overarching goal was to identify the factors
that are specific to the adoption process of ML systems
in clinics and are not yet sufficiently covered by
existing theories. We thus followed the steps of
directed content analysis in order to extend the
established conceptual framework based on TOE and
NASSS. In that regard, we used both frameworks as a
starting point that were integrated, adapted, and
expanded taking into account the qualitative data [20].
To analyze and understand the highly complex
process from a first readiness to a routine use of ML
systems, an in-depth analysis was necessary. We

therefore employed a qualitative approach to “see the
world through the eyes of the actors doing the acting”
[16:17] and conducted interviews with highly involved
experts (N=15). We formulated a semi-structured
interview guideline to lead the conversation and to
ensure that all relevant questions are posed. Due to the
qualitative approach, the guideline was kept open and
flexible to allow adaptations to the respective interview
partner, one’s position and knowledge base [33].
The qualitative data were collected from May to
October 2019 within Germany. In order to identify
suitable participants, we have searched for experts in
social networks, on clinic websites, and at relevant
conferences on ML in medicine. Qualified interviewed
experts (N=15) were chosen, who have detailed
knowledge of clinical processes, experience with ML
systems, and are involved in the respective decisionmaking processes [7]. We consider the additional
supplier perspective to be particularly useful to
triangulate the data [9]. The various experts are clinics’
managers, physicians, and managers of diagnostic HIT
suppliers. While three of the interviewed experts were
physicians, six hold a hybrid position (i.e. physicians
with additional leadership responsibilities), and six
were full-time managers with medical education. As
shown in Table 1, different medical disciplines were
considered in the interviews (e.g. radiology, pathology,
internal medicine) in order to allow for different
perspectives on medical diagnostic processes (e.g.
interpretation of medical scans, pathology slides,
electrocardiograms) and obtain more generalizable
results [5]. All experts had in common that they had
prior knowledge on ML systems due to research work,
pertinent projects, or product development processes.
Table 1: Study participant overview
Position
Specialty
Clinics (C): Key informants of clinics

Exp. in yr.

*: Physician with leadership responsibilities

01 Physician
Radiology
3
02 Physician
Radiology
15
03 Physician
Radiology
8
04 Physician*
Neuro-radiology
9
05 Physician*
Internal medicine 19
06 Physician*
Internal medicine 35
07 Physician*
Pathology
18
08 Physician*
Radiology
37
09 Physician*
Gynecology
40
10 CTO
Cardiology
8
11 CTO
Biomedicine
20
12 Director
Internal medicine 12
HIT Supplier (S): Key informants of clinics’ HIT
supplier companies
01 Director
Nephrology
20
02 Director
Biomedicine
22
03 Director
Genetics
10
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Participants work for several clinics and HIT
suppliers (i.e. nine different clinics, three HIT
suppliers). While three clinics are privately financed,
the others are public. Furthermore, all clinics and
suppliers are currently running projects related to ML.
On average, each expert interview lasted 49 minutes
and took place in private space. The interviews were
audio recorded and transcribed after mutual agreement.
In two interviews only, notes were taken as the
participant refused audio recording. The transcripts
were analyzed with the help of NVivo 12 software. We
applied an iterative multi-cycle coding process that is
in line with qualitative content analysis and that
consisted of two coding cycles, between which we
moved back and forth [40]. The first cycle comprised
three different types of coding: Using attribute coding
enabled us to receive descriptive information
concerning the participant. Hypothesis coding was
employed to consider the prespecified conceptual
framework (i.e. TOE and NASSS) and to examine the
suitability of existing factors regarding the adoption
process (e.g. clinic’s size). In contrast, the descriptive
coding approach allowed us to identify new aspects
that go beyond the conceptual framework by
disregarding formerly identified factors. Since the
coding procedure during the first cycle has led to a
large number of factors, we used pattern coding within
the second coding cycle to pull together the codes into
a smaller number of constructs [40].
During the research process, we employed several
practices to obtain rigor and trustworthiness. To begin
with, we defined a clear research question and
conceptual framework that we used as input for our
research design. Furthermore, we followed a
theoretical sampling approach by iterating between
data collection and analysis until theoretical saturation
was reached after the 15th interview [15]. The resulting
amount of interviews is comparable to other qualitative
studies in IS (healthcare) research [e.g. 6, 19]. Besides,
a multi-researcher triangulation took place. In that
sense, coding was intensively discussed between the
authors during the data analysis [9]. We also decided to
include the voice of participants and thus quoted
directly from the interviews while presenting our
findings [10:182].

4. Results and discussion of findings
As diagnostic procedures can differ within the
different medical specialties, the data analysis focuses
on common factors that affect the adoption of ML
systems for diagnostics in clinics and can be derived
across all disciplines. The key findings are structured
according to the TOE and NASSS framework in order
to describe the holistic adoption process of ML

systems. An integrative overview of all these factors
can be seen in Figure 1. In this regard, the first three
propositions (abbreviated: P) refer to clinic’s readiness
to adopt ML systems for diagnostics, while P4-6 apply
to the implementation phase. However, P7 shows the
relevance of patient data for both adoption phases.

Figure 1: Integrative overview of the findings
In the following, we present and discuss the results
of our data analysis. For this purpose, we structure our
findings according to the domains technological,
organizational, and environmental context as well as
the adopter system, condition, value proposition, and
the stand-alone domain patient data.
Technological context. The characteristics of a
technology are a factor that is already considered
within the original TOE framework [12]. Nevertheless,
as outlined earlier, ML systems encompass several
highly specific characteristics, that cannot be compared
to other technologies. Therefore, the existing general
factor “characteristics” is not sufficient to capture the
properties of ML and has to be specified further.
As one sub-factor of ML characteristics, the
interviewees point out the ‘lack of transparency’ of ML
systems as a major obstacle for clinic’s readiness to
adopt ML systems. ML systems based on neural
networks can consist of multiple processing layers and
up to millions of numerical weights hampering the
comprehensibility of ML systems to humans [8].
Especially in high-stakes decision-making processes
such as medical diagnostics, this can lead to major
issues. In this context, the experts state that physicians
need to know exactly, which are the critical features
considered by ML systems and how identified patterns
lead to conclusions to be able to assess the ML
system’s recommendation and suggest an appropriate
therapy. One of the experts underlines this aspect:
“You will never make these existential decisions
dependent on a black box, where it is not possible to
understand what led to the recommendation” (C-06).
Another sub-factor of ML characteristics is the ‘ability
to adapt’ their functioning if being retrained on novel
data. This can either become relevant when the ML
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system is transferred to another context (e.g. another
clinic) or needs to be retrained after some time as for
example new medical research results are gained or
patients’ demographic structure shifts. Clinics thus
have to deal with an opaque system that is able to
change its reasoning, making the outcome of a ML
system unpredictable. Accordingly, experts see the
adaptability of ML systems as another factor that has to
be addressed by clinics (S-01, S-03). In order to
prepare for the adoption of ML systems, clinics need to
have a clear strategy in place on how to cope with the
opacity and adaptability of self-learning ML systems.
We thus state our first proposition:
P1: The characteristics of ML systems (i.e. lack of
transparency, adaptability) will impede the readiness
of clinics to adopt ML systems.
Organizational context. Looking at the
organizational context domain, three factors emerged
during the interviews: size of clinic, medical directors’
ML support and clinic’s resources for ML.
The size of a clinic is similar to an existing TOE
factor that was also considered relevant in the context
of ML systems. In this sense, experts emphasized that
small clinics have usually less resources compared to
large clinics, which could hamper their readiness to
adopt ML systems (C-11). In addition, larger clinics
care for a larger number of different patients and thus
have access to higher amounts of patient data which is
needed to train ML systems appropriately (S-01).
Furthermore, experts state that the first decision to
adopt ML systems for diagnostic processes needs to be
supported by clinic’s medical directors to achieve
financial and non-financial support for the new
technology (C-03). In this regard, ML systems for
medical diagnostics affect the core business of clinics
and thus have a strategic relevance [49]. As medical
directors develop the clinic’s strategy, they are
responsible for paving the way regarding the readiness
of clinics to adopt ML systems. This is in line with
prior research that states the significance of medical
directors’ support regarding the readiness of clinics for
strategically relevant HITs [28, 47].
One of the most frequently stated factors within the
organizational context are clinic’s resources to get
ready to adopt ML systems. This factor incorporates
three sub-factors which are either in line with the
original TOE framework (i.e. ‘clinic’s technical
infrastructure’) or newly added (i.e. ‘financing
structure’, ‘expertise in medicine and data science’). In
line with existing literature [34], some of the experts
report that clinics frequently rely on a wide range of
clinical legacy systems, which are often proprietary to
the suppliers, not connected, and based on obsolete
hardware: “The primary challenge […] is that the
clinic usually consists of […] million proprietary

systems that are not connected” (C-01). However,
experts emphasize the importance of a highperformance technical infrastructure that can
efficiently access data from different sources to
achieve readiness for ML systems’ adoption (C-01, C07). Therefore, clinic’s technical infrastructure could
pose a major challenge for the introduction of ML
systems.
The interviewed experts furthermore point out the
problem of the current financing structure of clinics,
which leads to strict budgetary constraints (C-09). In
this regard, an interviewee states that one part of their
budget is assigned to daily costs such as medication.
The other part of the budget can be used to purchase
large-scale medical equipment like X-ray systems.
Thus, the development and set-up of ML systems is not
covered by either of the two parts and no specific ML
budget can be claimed (C-06).
Beyond that, there is a lack of personnel in clinics
having both expertise in medicine and data science:
“The shortage of medical specialists hits us twice as
hard. We feel this at the medical professional side [...],
but it is also very apparent at the technical side” (C10). Both fields of knowledge are regarded as highly
important for the readiness to adopt ML systems by the
experts (C-01, C-10, S-02). While a medical
background can help to identify relevant training data
or to assess the suggested conditions of the ML system,
technical expertise is needed to realize and train ML
systems, as presently, nearly no out-of-the-box ML
systems exist for the application in medicine, requiring
clinics to develop ML systems by themselves (C-01, C10, S-02). Therefore, specific expertise in the field of
data science is needed in addition to the medical
understanding in order to develop and set up ML
systems in clinics. In sum, we propose:
P2: A larger clinic size, medical directors’ ML
support, and the availability of resources for ML (i.e.
technical infrastructure, ML budget, expertise in the
field of medicine and data science) will facilitate the
readiness of clinics to adopt ML systems.
Environmental context. With regard to the
environmental context there are two relevant factors
influencing the readiness to adopt ML systems:
governmental regulations concerning ML and medical
ethics. Governmental regulations are a factor already
known from the original TOE framework.
Nevertheless,
the interviews
revealed some
particularities that are not covered by the general
concept and are described below. Medical ethics is a
factor that is not captured by TOE so far, but is
identified through our study.
In the field of medicine there are several
governmental regulations which must be taken into
consideration when adopting ML systems. The
Page 6321

following sub-factors could be identified: ‘medical
approval of ML systems’, ‘accountability’, and the
‘protection of sensitive personal data’.
The experts draw attention to the fact that HIT
offered on the market and used in clinics are subject to
several laws. That includes the need for medical
approval conducted by legal authorities or HIT
suppliers themselves (C-03). In the USA, the Food and
Drug Administration (FDA) is responsible for the
admission of medical products. In Europe, the HIT
suppliers themselves need to perform a conformity
assessment procedure, e.g. based on the Medical
Device Regulation (MDR) [14, 32]. As mentioned
before, most ML systems are currently being
developed by clinics themselves and have not
undergone any approval process (C-03). However,
legal approval of ML systems is not trivial, as the
system can learn from new experience and adapt
themselves as described above: “It is not obvious how
evidence can be obtained for an [ML] model that
differs significantly at the beginning, middle, and end
of the study. If you want to approve a medical device
today, you have to describe the intended use in detail”
(S-01). This legal gap is also addressed by an official
statement of the FDA that proposes a change to the
current regulation to be able to approve adaptable ML
systems [14]. A comparable position of the EU does
not exist. Therefore, legal ambiguities could represent
a hurdle for clinics to decide on the adoption of ML
systems for diagnostics.
In addition to the medical approval of a ML system,
there is the question of accountability for diagnoses.
The experts interviewed indicated that it is
questionable who takes over responsibility, if the
diagnosis that was prepared by an ML system is
inaccurate (C-04, C-10). It is also unclear who can be
held liable—the HIT provider, the clinic, or the
physician who is providing the medical diagnosis. An
expert underlines this aspect with the following words:
„Then there are certainly […] legal problems, for
example: who is responsible for the interpretation and
possibly wrong results of the ML model?” (C-10).
According to the current state of the art, ML systems
cannot be held responsible for their output, since a
registered physician is always obliged to validate and
interpret the system’s results and to perform the final
diagnosis (C-12). However, it would ease the decision
of clinics to opt for ML system if there was a legal
specification—especially if ML systems are
increasingly able to automate steps of sensitive
processes as diagnostics (C-10, C-11).
Another sub-factor which could be identified as
relevant for the initiation and adoption of ML systems
for diagnostics is the protection of sensitive personal
patient data. Patient data are considered as highly

sensitive and are under special protection by national
and international laws (C-02, S-02). For example, the
General Data Protection Regulation (GDPR) in Europe
only permits the processing of health data, if the
patient explicitly accepts or if the clinic can provide
particular reasons [13]. Thus, the respondents
emphasize clinics’ concerns to obtain the necessary
patient data to train the ML system (C-02, C-08).
Using ML systems for diagnostic processes fueled
medical ethical concerns among the interviewees. On
the one hand, ML systems are able to improve the
efficiency and effectivity of diagnostics (C-11, C-12,
S-02). On the other hand, the suggestions provided by
ML systems are deduced based on statistical methods
recognizing patterns in patient data that can be biased
(C-11). Furthermore, experts claimed that ML systems
that are fed with patient data could determine whether
a patient tends to develop a disease. This type of
medical application would contradict the “patient's
right not to know” (C-11). Summarizing these remarks,
we set up the proposition:
P3: Uncertainties in governmental regulations, strict
requirements for the protection of sensitive patient
data, and existing medical ethics will impede the
readiness of clinics to adopt ML systems.
Adopter system. The NASSS framework suggests
that the successful implementation of ML systems is
strongly influenced by the individuals who are
supposed to use the system or affected by their
suggestions. In this context, two ML specific factors
turned out to be relevant according to the interviews,
which further specify the factor: threat to physicians’
professional identity and patients’ ML reluctance.
Since ML systems have the ability to solve tasks
that were previously performed by humans, physicians
might feel interchangeable in their job (C-03, C-05, S03). ML systems are trained on large sets of data,
which exceed the experience of any single physician,
setting new standards for medical diagnostics. In this
regard, most experts are concerned that physicians
could reject ML system for their daily work: "As a
doctor who may have ten or 20 years of experience
[...], would I like to be taught by a machine [...]?” (S03). These concerns have recently found its way into
pertinent research, demonstrating the relevance of the
topic [e.g. 25].
The majority of the interviewees state the
importance of patients’ view on the use of ML systems
for medical diagnostics. Even though a physician is
still involved in the decision-making process, patients
might refuse the use of an ML system as the physician
may be influenced by suggestions for possible
conditions that are derived statistically and could be
affected by biases. Furthermore, personal sensitive
patient data have to be processed in order to gain
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results. Therefore, experts state patients’ acceptance of
ML systems as highly relevant for the implementation
(C-02, C-04, C-10). We thus conclude:
P4: The threat to the professional identity of
physicians and patients’ reluctance towards ML
systems will impede the implementation of ML
systems in clinics.
Condition. As specified within the NASSS
framework, the patient’s nature of condition impacts
the applicability of a technology. This does not only
hold true for conventional HIT but is also stated for
ML systems by the interviewed experts (C-02, C-07).
Therefore, the nature of the condition and the
according medical screening decides if ML can be
applied to support a diagnostic process at all. Even
though ML is considered a general-purpose technology
[8], the experts see difficulties to use ML systems, for
example, to recognize patterns of conditions in images
of organs, which either differ vastly from person to
person (e.g. female breast) or are in motion
continuously (e.g. human bowel) (C-02). Thus, the use
of ML systems will initially be limited to certain
conditions:
P5: The limited applicability of ML systems for
the diagnosis of specific conditions will impede the
implementation of ML systems in clinics.
Value proposition. The value proposition is the
third domain of the NASSS framework, we were able
to concretize by analyzing the interviews. According to
the experts, the implementation of ML systems could
result in the creation of value for both the physicians
and the patients (C-03, C-08, C-10).
Implementing ML systems in their daily work
enables physicians to improve the effectivity and
efficiency of their diagnostics since they can base their
decision on a broad data base that is evaluated within a
few seconds (C-12): “If you have the choice among a
pathologist who has already looked at 10,000 cuts […]
compared to one who has created only 500 findings,
whom would you chose? But […] AI has not only
10,000 but 500,000 findings in memory” (C-06). In this
regard, ML systems that are for example based on
image recognition algorithms can surpass the ability of
the human eye to capture details and patterns in X-rays
[3]. If used as a second opinion, ML system thus
increase the quality of physicians’ work (C-02, C-09).
Also, patients could directly benefit from a decision
that is faster and more informed if physicians use ML
systems for diagnostics (C-08, C-12). We thus propose:
P6: The additional value for physicians and patients
created through ML will facilitate the implementation
of ML systems in clinics.
Patient data. During the interviews, nearly all
experts stated the availability of patient data as crucial
for both the readiness of a clinic to adopt and

implement ML systems for diagnostics. In this regard,
patient data has to be available to develop and train the
ML system in the first place and subsequently retrain it
during use. This factor comprises certain sub-factors
which are described in the following.
According to the experts, most of the clinics
generate high volumes of patient data through their
daily diagnostic processes (C-03, S-01), which is
basically positive since an appropriate ‘amount of data’
are needed to train ML systems [8].
However, interviewing the experts revealed that
medical patient data are usually provided in a variety
of ‘proprietary data formats’ since many disparate
clinical legacy systems from different suppliers have to
interact in order to enable physicians to provide
laboratory tests, diagnostic images (e.g. X-rays), or
clinical notes. These proprietary data formats are often
difficult or impossible to convert, making the
generation of consistent formats highly problematic
(C-03). The problem of differing data formats in clinics
has already been recognized outside the ML context,
e.g. when adopting cloud solutions in healthcare
environments [e.g. 48]. Nevertheless, it is particularly
critical for the introduction and use of ML systems that
the patient data can be processed in order to be able to
train and retrain the system. Although first research has
been conducted to allow for the transformation of
different medical data types in one format [26], most
clinics have not yet been able to implement unified
standards for patient data in order to enable the
processing and analysis by ML systems.
Furthermore, patient data are often stored in
‘unstructured file types’ such as image, text, or video.
Experts raised the concern that physician letters are
frequently written in free text formats, which are filled
with synonyms and can be individually interpreted. For
example, personal formulations are used, such as the
description of a tumor’s size as comparable to a walnut
(C-01). Thus, the patient data are not only hard to
harness and has to be transferred in a machine-readable
format first (C-03), it also lacks common quality
standards for patient data, impeding the extraction of
generalizable patterns through ML. Clinics aiming to
adopt ML systems to support their diagnostics should
therefore establish a common language that physicians
apply when creating free texts. Such efforts are already
being driven by some national initiatives (C-12).
Moreover, it has been strongly emphasized by the
experts, that clinics, which want to use patient data to
train ML systems, need to anonymize the sensitive data
before processing it through an ML system (C-11).
However, ‘anonymizing data’ might remove valuable
information, which could be important regarding the
final diagnosis. For instance, information about a
person's residence could facilitate a diagnosis if a
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disease is more prevalent regionally (C-11). Therefore,
it is necessary for clinics to find ways to anonymize
patient data without losing relevant correlations. First
steps are already being taken in technical research to
balance the protection against the quality of sensitive
data effectively [e.g. 36].
In addition, there is no ‘basic truth’ for a healthy
patient as the human body is a highly complex, not
fully understood system. Therefore, no standard for an
entirely healthy human can be determined as every
medical examination could be influenced by the
selection of medical measures, undiscovered diseases,
or environmental conditions (S-02). In this context,
analyzing the quality of patient data is problematic: “A
standard for ‘what is healthy’ is not defined” (S-02).
According to the experts, the selection of the right
training data is especially important in a healthcare
context, since wrong diagnoses may have an impact on
patients’ lives. This leads to another aspect of patient
data, which has to be considered: their
‘representativeness’. Patients of clinics vary in many
aspects—from an outer perspective (e.g. age, gender,
hair color) as well as from the inner functioning (e.g.
size of organs, blood values). If ML systems are
predominantly trained based on a demographically or
regionally distorted database, false conclusions could
be drawn by the system. In this context, an expert
raised the example of a ML system supporting the
detection of skin melanomas, which is mainly trained
on a sample of patients with a similar phenotype.
Therefore, this pre-trained ML system cannot be easily
transferred to patients of other ages or with other skin
pigmentation (C-01). As training data for supervised
learning need to be labelled by humans, the same could
be said regarding the expertise and working philosophy
of physicians, which could be highly heterogeneous
depending on physician’s knowledge state and working
environment (C-07, C-10).
Another aspect that influences the availability of
ML systems in clinics is the ‘digitization of patient
data’. Even though high volumes of data are generated,
many processes in clinics are still paper-based
impeding the availability of patient data in a digitized
form: “Data are often not digitized, much is still in
paper files, not structured, which means that the data
availability is really extremely [...] poor" (C-03). This
observation is in line with prior research concerning
clinics who are lagging behind at using digitized
technologies [e.g. 21]. As a consequence, the
interviewed experts see the integration of an electronic
medical record system as a prerequisite for the
application of ML systems (C-12, C-03).
Additionally, the availability of patient data is
limited due to difficulties of ‘patient data sharing’.
Although some experts state that their clinics already

have some special data networks in place, most
healthcare organizations are still not connected. To
enhance the availability of patient data in order to train
ML systems, more secure internal (within clinic) and
external data networks (e.g. clinic-to-primary care)
should be established (C-03).
The availability of patient data is not only a factor
that decides on the readiness of a clinic to adopt ML
systems, but must also be guaranteed during
implementation phase in order to feed and retrain ML
systems. Therefore, we identify the availability of
patient data as an overarching factor as it influences
both the readiness and implementation phase:
P7: The availability of large volumes of digitized
patient data (that are structured, uniformly formatted,
anonymized, and representative) will facilitate the
readiness of clinics to adopt and the implementation
of ML systems in clinics.

5. Conclusion
ML has an impact on all areas of human life
including the healthcare system. In this regard, ML
systems offer the opportunity to make diagnostics more
efficient and informed. However, in order to harness
ML for such an application, clinics need to deeply
integrate ML systems into their clinical practice—a
challenge that most clinics have not yet been able to
overcome [24]. Since clinics own highly individual,
human-oriented processes, it is crucial for IS
researchers to reflect on this specific context [11].
The prior research is lagging behind to provide
empirically proven factors that influence the
integration of ML systems in clinics for diagnostic
processes. To address this shortcoming, we set up a
qualitative study and structured our findings in an
integrated overview based on the frameworks TOE and
NASSS. Before we discuss our contributions to theory
and practice, it is necessary to clarify the limitations of
this study. Since we pursued a qualitative approach,
our results are based on the expertise of 15
interviewees. In order to counter potential problems of
generalizability, we have applied various criteria to
ensure rigor and trustworthiness of our study (e.g.
theoretical saturation, triangulation, inclusion of
multiple medical disciplines). Nevertheless, it might be
interesting for further research to perform a
quantitative study to verify the stated propositions and
validate the proposed framework (i.e. P1-P7).
Furthermore, the interviews were conducted in
Germany only. Since the healthcare systems vary
across nations, interviewing experts from other regions
could lead to differing results. In addition, the rapid
development of increasingly advanced ML algorithms
could lead to systems, which are able to not only
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augment but automate diagnostic processes.
Investigating automated diagnostics could produce
different findings, even though the results obtained in
this study could provide first indications. Nevertheless,
our study makes several important contributions. To
begin with, it could be shown that the TOE and
NASSS framework can be applied, but have to be
integrated and expanded in order to explain the full
adoption process of ML systems for diagnostics in
clinics. On this basis, we are the first to provide an
integrative overview of readiness and implementation
factors regarding ML systems in clinics. The overview
includes three propositions that affect the readiness of
a clinic to adopt ML systems and three that impact the
subsequent implementation phase to put these systems
into clinical use. Availability of patient data is found to
be overarching as it influences both the readiness and
implementation phase. Therefore, we contribute to
adoption research in health informatics, which has
recently called to look beyond the mere readiness to
adopt HIT in healthcare organizations and to
emphasize its subsequent implementation [17]. In
addition, our study holds important practical
implementations. In this regard, the key findings could
guide medical directors of clinics aiming to integrate
ML systems within their diagnostic processes. For
example, clinics are still lacking strategies to
implement unified patient data formats, even though
research efforts in this area already exist. Thus, our
study could lay a foundation to avoid pitfalls that could
occur during the readiness or implementation phase of
ML systems in a medical environment.

6. References
[1] Aboelmaged, M.G., “Predicting e-readiness at firm-level:
An analysis of technological, organizational and
environmental (TOE) effects on e-maintenance readiness in
manufacturing firms”, International Journal of Information
Management 34(5), 2014, pp. 639–651.
[2] Agwunobi, A., and P. Osborne, “Dynamic capabilities
and healthcare: A framework for enhancing the competitive
advantage of hospitals”, California Management Review
58(4), 2016, pp. 141–161.
[3] Akcay, S., M.E. Kundegorski, C.G. Willcocks, and T.P.
Breckon, “Using deep convolutional neural network
architectures for object classification and detection within xray baggage security imagery”, IEEE Transactions on
Information Forensics and Security 13(9), 2018, pp. 2203–
2215.
[4] Bardhan, I., H. Chen, and E. Karahanna, “Connecting
systems, data, and people: A multidisciplinary research
roadmap for chronic disease management”, MIS Quarterly
44(1), 2020, pp. 185–201.
[5] Benbasat, I., D.K. Goldstein, and M. Mead, “The case
research strategy in studies of information systems”, MIS

Quarterly: Management Information Systems 11(3), 1987,
pp. 369–386.
[6] Blankenhagel, K.J., M.-M. Theilig, H. Koch, A.-K. Witte,
and R. Zarnekow, “Challenges for Preventive Digital Stress
Management Systems – Identifying Requirements by
Conducting Qualitative Interviews”, Proceedings of the 52nd
Hawaii International Conference on System Sciences, (2019),
3810–3819.
[7] Bogner, A., B. Littig, and W. Menz, “Introduction: Expert
interviews—An introduction to a new methodological
debate”, In A. Bogner, B. Littig and W. Menz, eds.,
Interviewing Experts. Palgrave Macmillan, London, 2009, 1–
13.
[8] Brynjolfsson, E., and T. Mitchell, “What can machine
learning do? Workforce implications”, Science 358(6370),
2017, pp. 1530–1534.
[9] Carter, N., D. Bryant-Lukosius, A. Dicenso, J. Blythe,
and A.J. Neville, “The use of triangulation in qualitative
research”, Oncology Nursing Forum 41(5), 2014, pp. 545–
547.
[10] Creswell, J.W., Qualitative inquiry and research design:
Choosing among five traditions, Sage, Thousand Oaks,
California, USA, 2007.
[11] Davison, R.M., and M.G. Martinsons, “Context is king!
Considering particularism in research design and reporting”,
Journal of Information Technology 31(3), 2015, pp. 241–
249.
[12] DePietro, R., E. Wiarda, and M. Fleischer, “The context
for change: Organization, technology and environment”, In
L. Tornatzky and M. Fleischer, eds., The Process of
Technological Innovation. Lexington Books, Lexington,
USA, 1990, 152–175.
[13] European Parliament, Regulation (EU) 2016/679 of the
european parliament and of the council, 2016.
[14] FDA, Proposed regulatory framework for modifications
to artificial intelligence/Machine learning (AI/ML)-based
software as a medical device (SaMD)-discussion paper and
request for feedback, 2019.
[15] Flick, U., “Triangulation in qualitative research”, In U.
Flick, E. von Kardoff and I. Steinke, eds., A Companion to
Qualitative Research. Sage, London, UK, 2004, 178–183.
[16] Greener, S., Business research methods, Ventus
Publishing, London, UK, 2008.
[17] Greenhalgh, T., J. Wherton, C. Papoutsi, et al., “Beyond
adoption: A new framework for theorizing and evaluating
nonadoption, abandonment, and challenges to the scale-up,
spread, and sustainability of health and care technologies”,
Journal of Medical Internet Research 19(11), 2017.
[18] He, J., S.L. Baxter, J. Xu, J. Xu, X. Zhou, and K. Zhang,
“The practical implementation of artificial intelligence
technologies in medicine”, Nature Medicine 25(1), 2019, pp.
30–36.
[19] Hofmann, P., P. Rust, and N. Urbach, “Machine learning
approaches along the radiology value chain – Rethinking
value propositions.”, Proceedings of the 27th European
Conference on Information Systems, (2019).
[20] Hsieh, H.-F., and S.E. Shannon, “Three approaches to
Page 6325

qualitative content analysis”, Qualitative Health Research
15(9), 2005, pp. 1277–1288.
[21] Hufnagl, C., E. Doctor, L. Behrens, C. Buck, and T.
Eymann, “Digitisation along the patient pathway in
hospitals”, Proceedings of the 27th European Conference on
Information Systems, (2019).
[22] Hung, S.-Y., W.-H. Hung, C.-A. Tsai, and S.-C. Jiang,
“Critical factors of hospital adoption on CRM system:
Organizational and information system perspectives”,
Decision Support Systems 48(4), 2010, pp. 592–603.
[23] Jordan, M.I., and T.M. Mitchell, “Machine learning:
Trends, perspectives, and prospects”, Science 349(6245),
2015, pp. 255–260.
[24] Kuan, R., “Adopting AI in health care will be slow and
difficult”, Harvard Business Review Digital Articles, 2019.
[25] Lebovitz, S., “Diagnostic doubt and artificial
intelligence: An inductive field study of radiology work”,
Proceedings of the 40th International Conference on
Information Systems, (2019).

Kuhn, “ARX - A comprehensive tool for anonymizing
biomedical data”, Proceedings of Annual Symposium
American Medical Informatics Association, (2014), 984–993.
[37] Pumplun, L., and P. Buxmann, “Intelligent Systems and
Hospitals: Joint Forces in the Name of Health?”, Proceedings
of the 15th International Conference on
Wirtschaftsinformatik, (2020).
[38] Rai, A., and S. Sarker, “Editor’s comments: Nextgeneration digital platforms: Toward human-AI hybrids”,
MIS Quarterly 43(1), 2019, pp. iii–ix.
[39] Russell, S.J., and P. Norvig, Artificial intelligence: A
modern approach, Addison Wesley, Boston, MA, USA,
2016.
[40] Saldaña, J., The coding manual for qualitative
researchers, Sage, London, UK, 2009.
[41] Shahid, N., T. Rappon, and W. Berta, “Applications of
artificial neural networks in health care organizational
decision-making: A scoping review”, PLoS ONE 14(2),
2019, pp. 1–22.

[26] Lee, J., C. Liu, N. Shang, et al., Generate the concept
representation using OMOP ontology graph, New York,
USA, 2019.
[27] Li, T., Y. Zhang, C. Gong, et al., “Prevalence of
malnutrition and analysis of related factors in elderly patients
with COVID-19 in Wuhan, China”, European Journal of
Clinical Nutrition, 2020.
[28] Lian, J.W., D.C. Yen, and Y.T. Wang, “An exploratory
study to understand the critical factors affecting the decision
to adopt cloud computing in Taiwan hospital”, International
Journal of Information Management 34(1), 2014, pp. 28–36.
[29] Liu, D., N. Sepulveda, and M. Zheng, “Artificial neural
networks condensation: A strategy to facilitate adaption of
machine learning in medical settings by reducing
computational burden”, ArXiv, 2018.
[30] Mayer, K.J.R., and R.T. Sparrowe, “From the editors
integrating theories in AMJ articles”, Academy of
Management Journal 56(4), 2013, pp. 917–922.
[31] McCarthy, J., What is Artificial Intelligence?, Stanford,
2007.
[32] Migliore, A., “On the new regulation of medical devices
in europe”, Expert Review of Medical Devices 14(12), 2017,
pp. 921–923.
[33] Myers, M.D., and M. Newman, “The qualitative
interview in IS research: Examining the craft”, Information
and Organization 17(1), 2007, pp. 2–26.
[34] Panch, T., H. Mattie, and L.A. Celi, “The ‘inconvenient
truth’ about AI in healthcare”, npj Digital Medicine 2(1),
2019, pp. 4–6.
[35] Paton, C., and S. Kobayashi, “An open science approach
to artificial intelligence in healthcare”, Yearbook of medical
informatics 28(1), 2019, pp. 47–51.
[36] Prasser, F., F. Kohlmayer, R. Lautenschläger, and K.A.

[42] Shaw, J., F. Rudzicz, T. Jamieson, and A. Goldfarb,
“Artificial intelligence and the implementation challenge”,
Journal of Medical Internet Research 21(7), 2019.
[43] Thrall, J.H., X. Li, Q. Li, et al., “Artificial intelligence
and machine learning in radiology: Opportunities, challenges,
pitfalls, and criteria for success.”, Journal of the American
College of Radiology 15(3), 2018, pp. 504–508.
[44] Topol, E.J., “High-performance medicine: the
convergence of human and artificial intelligence”, Nature
Medicine 25(1), 2019, pp. 44–56.
[45] Tornatzky, L.G., and K.J. Klein, “Innovation
characteristics and innovation adoption-implementation: A
meta-analysis of findings.”, IEEE Transactions on
Engineering Management EM-29(1), 1982, pp. 28–45.
[46] Vardell, E.J., and M. Moore, “Isabel, a clinical decision
support system”, Medical Reference Services Quarterly
30(2), 2011, pp. 158–166.
[47] Yang, Z., J. Sun, Y. Zhang, and Y. Wang,
“Understanding SaaS adoption from the perspective of
organizational users: A tripod readiness model”, Computers
in Human Behavior 45, 2015, pp. 254–264.
[48] Zhang, Y., M. Qiu, C.W. Tsai, M.M. Hassan, and A.
Alamri, “Health-CPS: Healthcare cyber-physical system
assisted by cloud and big data”, IEEE Systems Journal 11(1),
2017, pp. 88–95.
[49] Zhu, K., and K.L. Kraemer, “Post-adoption variations in
usage and value of e-business by organizations: Crosscountry evidence from the retail industry”, Information
Systems Research 16(1), 2005, pp. 61–84.
[50] Zhu, K., K.L. Kraemer, and S. Xu, “The process of
innovation assimilation by firms in different countries: A
technology diffusion perspective on e-business”,
Management Science 52(10), 2006, pp. 1557–1576.

Page 6326

